Peruvoside: Difference between revisions

Peruvoside
Clinical data
ATC code	C01AX02 (WHO) ;
Identifiers
	IUPAC name (3S,5R,10R,13R,14S,17R)-3-[(2S,5R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy -13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde;
CAS Number	1182-87-2;
PubChem CID	14449;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C30H44O9
Molar mass	548.665 g/mol

Revision as of 14:57, 20 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Peruvoside (or cannogenin thevetoside) is a cardiac glycoside.^[1]

↑ Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia nereifolia; Chemical, Pharmacological, and Clinical Studies. Arora, R. B.; Rangaswami, S. (1972), Publisher: (Thomson, New Delhi, India)

Revision as of 18:17, 27 September 2011 (view source) WikiBot (talk \| contribs) m (Protected "Peruvoside": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))		Revision as of 14:57, 20 August 2012 (view source) WikiBot (talk \| contribs) m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) Newer edit →
Line 29:		Line 29:
	{{CMG}}		{{CMG}}

	~~{{Editor Join}}~~

Clinical data

ATC code	C01AX02 (WHO)
Identifiers
IUPAC name (3S,5R,10R,13R,14S,17R)-3-[(2S,5R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy -13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
CAS Number	1182-87-2
PubChem CID	14449
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₀H₄₄O₉
Molar mass	548.665 g/mol